AP NEWS
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Globe Newswire
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation.

VITALIBIS, INC. Appoints Global Authority In The Fields of Wellness and Direct Selling Oran Arazi-Gamliel To Advisory Board

February 19, 2019

LAS VEGAS, Feb. 19, 2019 (GLOBE NEWSWIRE) -- VITALIBIS, INC. (OTCQB: VCBD), a technology based formulator of premium, full-spectrum phytocannabinoid rich hemp oil products with naturally occurring cannabidiol (CBD), along with safe skincare and certified organic nutritional products, announced today the appointment of Oran Arazi-Gamliel to the Company’s Advisory Board. Arazi-Gamliel has extensive experience in the fields of wellness, direct selling and global commercial strategies. Arazi-Gamliel serves as an advisor to CEOs, investment banks and strategy consulting firms, and holds an MBA in International Business.

With over 20 years in general management and C-Suite positions in the global wellness and direct selling arenas, Arazi-Gamliel has operated in the North America, Australia, Japan, UK, Russia and Israel markets. During his 20-year tenure, Arazi-Gamliel was responsible for developing new business strategies, as well as restructuring numerous direct selling operations.

In his latest executive position (2011-2017), Arazi-Gamliel served as Chief Global Officer and Head of M&A of Rodan + Fields, a prestige dermatology-inspired skincare brand that grew to over $1.5B in 2017 and became the number 1 skin-care brand in North America. In this position, Arazi-Gamliel was instrumental in creating key field behavioral programs and the global market entry strategies.

Arazi-Gamliel’s current global business development firm utilizes his exclusive industry expertise and global networks to develop and execute robust commercial strategies for clients such as Avon, NuSkin, Oriflame and Cerberus Operations and Advisory Company.

Steven Raack, CEO and Co-Founder of Vitalibis, stated, “As a highly respected global leader, having Arazi-Gamliel as a member of Team Vitalibis is an honor. His strategy, brand building, business development and global experience is well recognized worldwide. In addition, having Arazi-Gamliel based in Israel opens up strategic opportunites for us, as Israel continues to lead the world in the field of cannabis research.”

Oran Arazi-Gamliel stated, “I’m humbled and honored to take an advisory role with Steve and his team. Steve’s mission and passion for safe and effective products with naturally occurring cannabidiol (CBD) comes at the time when this wellness segment is rapidly transforming and growing globally. It is an extremely excting time to be operating in this space and I am looking forward to contributing to Vitalibis’ success.”

About Vitalibis, Inc.

Vitalibis is a socially conscious brand focused on people, products and the planet. We are a technology based formulator of premium, full spectrum phyto-cannabinoid rich hemp products with naturally occurring cannabidiol (CBD), along with safe skincare and certified organic nutritional products. Our Ambassador program combines the best elements of social selling, ecommerce and affiliate marketing into one - empowering our people and social mission driven ecosystem.

For additional information, www.vitalibis.com

Contact:Vitalibis Inc.702-944-9620 info@vitalibis.com

FORWARD LOOKING STATEMENT This news release includes forward-looking statements that reflect Vitalibis Inc. current expectations about its future results, performance, prospects and opportunities Vitalibis, Inc. has tried to identify these forward-looking statements by using words and phrases such as “may”, “will”, “expects”, “anticipates”, “believes”, “intends”, “estimates”, “should”, “typical”, “we are confident” or similar expressions. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company’s actual results, performance, prospects of opportunities for the remainder of 2019 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.